Paper3925344
Inhibition of the Prausnitz-Küstner reaction by an immunoglobulin epsilon-chain fragment synthesized in E. coli.
Geha RS and 2 others. Nature, 1985. Cited by 68 papers, by iCite.
Cite this record
ConductScience Library. Inhibition of the Prausnitz-Küstner reaction by an immunoglobulin epsilon-chain fragment synthesized in E. coli. Papers, record 3925344. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3925344
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Escherichia coli | Major topic |
| Immunoglobulin E | Major topic |
| Immunoglobulin Heavy Chains | Major topic |
| Immunoglobulin epsilon-Chains | Major topic |
| Skin | Major topic |
| Genes | |
| Humans | |
| Immunoassay | |
| Immunoglobulin Constant Regions | |
| Multiple Myeloma |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| AI-10060 | NIAID NIH HHS | United States | PubMed | PubMed | |
| AI20373 | NIAID NIH HHS | United States | R01AI020373 | PubMed and NIH | NIH RePORTER |
| AM31925 | NIADDK NIH HHS | United States | R01AM031925 | PubMed and NIH | NIH RePORTER |
Cited by17
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 68 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39041740 | Whence and wherefore IgE? | Immunol Rev | 2024 | https://conductscience.org/library/papers/39041740 | PubMed |
| 36098746 | Induction of natural IgE by glucocorticoids. | J Exp Med | 2022 | https://conductscience.org/library/papers/36098746 | PubMed |
| 35022271 | A Recombinant Ig Fragment (IgCw-γεκ) Comprising the Cγ1-Cε2-4 and Cκ Domains Is an Alternative Reagent to Human IgE. | J Immunol | 2022 | https://conductscience.org/library/papers/35022271 | PubMed |
| 33328726 | Chronic Rhinosinusitis with Nasal Polyps: Targeting IgE with Anti-IgE Omalizumab Therapy. | Drug Des Devel Ther | 2020 | https://conductscience.org/library/papers/33328726 | PubMed |
| 31466324 | Tracing IgE-Producing Cells in Allergic Patients. | Cells | 2019 | https://conductscience.org/library/papers/31466324 | PubMed |
| 30053010 | IgE repertoire and immunological memory: compartmental regulation and antibody function. | Int Immunol | 2018 | https://conductscience.org/library/papers/30053010 | PubMed |
| 23675156 | Inhibition of IgE Activity to Bind its High Affinity Receptor (FcεRIα) by Mouse Anti-IgE Cε3∼4 Monoclonal Antibody (QME5). | Int J Biomed Sci | 2009 | https://conductscience.org/library/papers/23675156 | PubMed |
| 22249450 | Sequential class switching is required for the generation of high affinity IgE antibodies. | J Exp Med | 2012 | https://conductscience.org/library/papers/22249450 | PubMed |
| 18941743 | Characterisation of an engineered trastuzumab IgE antibody and effector cell mechanisms targeting HER2/neu-positive tumour cells. | Cancer Immunol Immunother | 2009 | https://conductscience.org/library/papers/18941743 | PubMed |
| 18703499 | Attenuation of IgE affinity for FcepsilonRI radically reduces the allergic response in vitro and in vivo. | J Biol Chem | 2008 | https://conductscience.org/library/papers/18703499 | PubMed |
| 3584468 | Metabolism of immunoglobulin E in patients with markedly elevated serum immunoglobulin E levels. | J Clin Invest | 1987 | https://conductscience.org/library/papers/3584468 | PubMed |
| 3553373 | Expression of recombinant immunoglobulin genes to produce novel molecules with specific functions. | Immunol Res | 1986 | https://conductscience.org/library/papers/3553373 | PubMed |
| 3123993 | The mast cell binding site on human immunoglobulin E. | Nature | 1988 | https://conductscience.org/library/papers/3123993 | PubMed |
| 2965737 | Human recombinant interleukin 4 induces Fc epsilon R2/CD23 on normal human monocytes. | J Exp Med | 1988 | https://conductscience.org/library/papers/2965737 | PubMed |
| 2512581 | Blocking of passive sensitization of human mast cells and basophil granulocytes with IgE antibodies by a recombinant human epsilon-chain fragment of 76 amino acids. | Proc Natl Acad Sci U S A | 1989 | https://conductscience.org/library/papers/2512581 | PubMed |
| 2430285 | Biological properties of a recombinant human immunoglobulin epsilon-chain fragment. | Proc Natl Acad Sci U S A | 1986 | https://conductscience.org/library/papers/2430285 | PubMed |
| 2161530 | Muscarinic and beta-adrenergic depression of the slow Ca2(+)-activated potassium conductance in hippocampal CA3 pyramidal cells is not mediated by a reduction of depolarization-induced cytosolic Ca2+ transients. | Proc Natl Acad Sci U S A | 1990 | https://conductscience.org/library/papers/2161530 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| IGHE | 3497 | PubTator's text mining | https://conductscience.org/library/genes/3497 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3925344
GET https://conductscience.org/api/papers/v1/3925344/authors